Black Diamond Therapeutics Inc (BDTX) stock news · rev $70.0M
Black Diamond Therapeutics Inc (BDTX) is a biotechnology company listed on NASDAQ.
This BDTX news page leads with what Black Diamond Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for BDTX yet. We will not pad this page with generic market recap.
Latest reported BDTX revenue for 2025-12-31 was $70.0M. Net income was $22.4M. BDTX currently screens at market cap $95.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BDTX stock page; for the tape open the quote page.
BDTX stock news FAQ
What are BDTX's latest revenue and net income?
Latest cached Black Diamond Therapeutics Inc (BDTX) revenue for Dec 31, 2025 was $70.0M. Net income was $22.4M. Statements: https://lician.com/financials/bdtx
What is BDTX's market cap?
Black Diamond Therapeutics Inc (BDTX) market cap is $95.7M on the latest cached fundamentals snapshot.
What kind of company is BDTX?
Black Diamond Therapeutics Inc (BDTX) is a biotechnology company listed on NASDAQ.
Where is BDTX stock news listed?
Cached stock news for Black Diamond Therapeutics Inc (BDTX) is listed at https://lician.com/news/bdtx. Filings: https://lician.com/sec/bdtx
Not investment advice.